Literature DB >> 9605770

Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: the role of the alpha6 and beta4 integrin subunits.

H Sun1, S A Santoro, M M Zutter.   

Abstract

Our previous studies demonstrated that reexpression of the alpha2beta1 integrin by a poorly differentiated breast carcinoma cell line, Mm5MT, resulted in dramatic reversion of a malignant phenotype to a differentiated epithelial phenotype. We hypothesized that reexpression of the alpha2beta1 integrin may regulate expression of other genes, the expression of which contributed to the dramatic phenotypic change. We now show that reexpression of the alpha2beta1 integrin results in up-regulation of both the alpha6 and beta4 integrin subunits but no change in the alpha1, alpha3, alpha5, or beta1 integrin subunits or E-cadherin. To further investigate the role of the alpha6 and beta4 integrin subunits in mediating the phenotypic changes elicited by reexpression of the alpha2beta1 integrin, the alpha6 or beta4 integrin subunit was expressed in our Mm5MT model. Expression of either subunit increased adhesion to laminin-1. Although adhesion to collagen was unaltered, contraction of three-dimensional collagen gels was reduced. Expression of either the alpha6 or beta4 integrin subunit also restored some aspects of a less malignant phenotype, including the acquisition of contact inhibition and diminution of anchorage-dependent and anchorage-independent growth rates. The alpha6 and beta4 transfectants formed three-dimensional organized structures when grown in gels of reconstituted basement membrane but did not form the highly branched, duct-like structures formed by the alpha2 transfectants. In contrast to the reduced invasiveness of the alpha2 transfectants, the alpha6 and beta4 transfectants retained an invasive phenotype. These results suggest that expression of the alpha6beta4 integrin contributes to some but not all of the phenotypic changes elicited by reexpression of the alpha2 integrin subunit and modulates the function of other integrins on these cells. Using our Mm5MT model, we are defining the cascade of integrin expression required for maintenance of the differentiated mammary epithelial cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Collagen receptor control of epithelial morphogenesis and cell cycle progression.

Authors:  M M Zutter; S A Santoro; J E Wu; T Wakatsuki; S K Dickeson; E L Elson
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Integrin function in breast carcinoma progression.

Authors:  L M Shaw
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

3.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis.

Authors:  Xin A Zhang; Alexander R Kazarov; Xiuwei Yang; Alexa L Bontrager; Christopher S Stipp; Martin E Hemler
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

Review 5.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 6.  Integrin laminin receptors and breast carcinoma progression.

Authors:  A M Mercurio; R E Bachelder; J Chung; K L O'Connor; I Rabinovitz; L M Shaw; T Tani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

7.  CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture.

Authors:  Julia Kirshner; Charng-Jui Chen; Pingfang Liu; Jie Huang; John E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

8.  Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.

Authors:  K L O'Connor; L M Shaw; A M Mercurio
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

9.  p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB.

Authors:  R E Bachelder; M J Ribick; A Marchetti; R Falcioni; S Soddu; K R Davis; A M Mercurio
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

10.  Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition.

Authors:  D Krubasik; N G Iyer; W R English; A A Ahmed; M Vias; C Roskelley; J D Brenton; C Caldas; G Murphy
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.